| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,072,631 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$7,181,571 |
|
|
|
Indirect Value
|
$1,005,203 |
|
|
| Total
Shares |
11,760,076 |
|
|
| Total
Value |
$8,186,774 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -250.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-16 |
4 |
S |
$3.67 |
$91,778 |
I/I |
(25,035) |
1,867,951 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-12 |
4 |
S |
$3.70 |
$142,683 |
I/I |
(38,563) |
1,954,423 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-11-10 |
4 |
B |
$3.73 |
$8,579 |
I/I |
2,300 |
133,741 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-13 |
4 |
S |
$3.76 |
$230,942 |
I/I |
(61,437) |
1,892,986 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
• • • |
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
I/I |
(50,000) |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
officerTitle |
• • • |
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
D/D |
(50,000) |
26,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-18 |
4 |
AS |
$7.78 |
$53,714 |
I/I |
(6,900) |
220,800 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-17 |
4 |
AS |
$7.90 |
$54,542 |
I/I |
(6,900) |
227,700 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-27 |
4 |
AS |
$8.02 |
$55,322 |
I/I |
(6,900) |
207,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-13 |
4 |
AS |
$8.09 |
$55,846 |
I/I |
(6,900) |
234,600 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-26 |
4 |
AS |
$8.09 |
$55,852 |
I/I |
(6,900) |
213,900 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-23 |
4 |
AS |
$8.27 |
$57,863 |
I/I |
(7,000) |
332,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-13 |
4 |
AS |
$8.28 |
$57,966 |
I/I |
(7,000) |
290,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-22 |
4 |
AS |
$8.37 |
$58,589 |
I/I |
(7,000) |
339,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-12 |
4 |
AS |
$8.37 |
$58,616 |
I/I |
(7,000) |
297,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-08 |
4 |
AS |
$8.41 |
$58,837 |
I/I |
(7,000) |
304,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-07 |
4 |
AS |
$8.46 |
$58,397 |
I/I |
(6,900) |
248,400 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-31 |
4 |
AS |
$8.48 |
$58,521 |
I/I |
(6,900) |
200,100 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-08-01 |
4 |
AS |
$8.54 |
$58,909 |
I/I |
(6,900) |
193,200 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-07-12 |
4 |
AS |
$8.55 |
$59,000 |
I/I |
(6,900) |
241,500 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-07 |
4 |
AS |
$8.60 |
$60,224 |
I/I |
(7,000) |
311,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-01 |
4 |
AS |
$8.62 |
$60,361 |
I/I |
(7,000) |
325,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-06-28 |
4 |
AS |
$8.68 |
$59,911 |
I/I |
(6,900) |
269,100 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-18 |
4 |
AS |
$8.71 |
$60,955 |
I/I |
(7,000) |
346,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-05-17 |
4 |
AS |
$8.76 |
$61,296 |
I/I |
(7,000) |
35,300 |
|
- |
|
148 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
